BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 28320384)

  • 1. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; Boulle A; Vogt M; Gupta-Wright A; Nicol MP; Meintjes G
    BMC Med; 2017 Mar; 15(1):67. PubMed ID: 28320384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; van Wyk G; Vogt M; Pahlana P; Nicol MP; Meintjes G
    BMC Med; 2015 Aug; 13():192. PubMed ID: 26275908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.
    Shah M; Hanrahan C; Wang ZY; Dendukuri N; Lawn SD; Denkinger CM; Steingart KR
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD011420. PubMed ID: 27163343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    AIDS; 2012 Aug; 26(13):1635-43. PubMed ID: 22555166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determine TB-LAM point-of-care tuberculosis assay predicts poor outcomes in outpatients during their first year of antiretroviral therapy in South Africa.
    Kerkhoff AD; Longley N; Kelly N; Cross A; Vogt M; Wood R; Hermans S; Lawn SD; Harrison TS
    BMC Infect Dis; 2020 Jul; 20(1):555. PubMed ID: 32736601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.
    Drain PK; Losina E; Coleman SM; Giddy J; Ross D; Katz JN; Walensky RP; Freedberg KA; Bassett IV
    BMC Infect Dis; 2014 Feb; 14():110. PubMed ID: 24571362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data.
    Broger T; Koeppel L; Huerga H; Miller P; Gupta-Wright A; Blanc FX; Esmail A; Reeve BWP; Floridia M; Kerkhoff AD; Ciccacci F; Kasaro MP; Thit SS; Bastard M; Ferlazzo G; Yoon C; Van Hoving DJ; Sossen B; García JI; Cummings MJ; Wake RM; Hanson J; Cattamanchi A; Meintjes G; Maartens G; Wood R; Theron G; Dheda K; Olaru ID; Denkinger CM;
    Lancet Glob Health; 2023 Jun; 11(6):e903-e916. PubMed ID: 37202025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study.
    Reddy KP; Gupta-Wright A; Fielding KL; Costantini S; Zheng A; Corbett EL; Yu L; van Oosterhout JJ; Resch SC; Wilson DP; Horsburgh CR; Wood R; Alufandika-Moyo M; Peters JA; Freedberg KA; Lawn SD; Walensky RP
    Lancet Glob Health; 2019 Feb; 7(2):e200-e208. PubMed ID: 30683239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce.
    Peter JG; Theron G; Muchinga TE; Govender U; Dheda K
    PLoS One; 2012; 7(7):e39966. PubMed ID: 22815718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid urine-based screening for tuberculosis to reduce AIDS-related mortality in hospitalized patients in Africa (the STAMP trial): study protocol for a randomised controlled trial.
    Gupta-Wright A; Fielding KL; van Oosterhout JJ; Wilson DK; Corbett EL; Flach C; Reddy KP; Walensky RP; Peters JA; Alufandika-Moyo M; Lawn SD
    BMC Infect Dis; 2016 Sep; 16(1):501. PubMed ID: 27659507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis Case Finding With Combined Rapid Point-of-Care Assays (Xpert MTB/RIF and Determine TB LAM) in HIV-Positive Individuals Starting Antiretroviral Therapy in Mozambique.
    Floridia M; Ciccacci F; Andreotti M; Hassane A; Sidumo Z; Magid NA; Sotomane H; David M; Mutemba E; Cebola J; Mugunhe RJ; Riccardi F; Marazzi MC; Giuliano M; Palombi L; Mancinelli S
    Clin Infect Dis; 2017 Nov; 65(11):1878-1883. PubMed ID: 29020319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data.
    Broger T; Nicol MP; Székely R; Bjerrum S; Sossen B; Schutz C; Opintan JA; Johansen IS; Mitarai S; Chikamatsu K; Kerkhoff AD; Macé A; Ongarello S; Meintjes G; Denkinger CM; Schumacher SG
    PLoS Med; 2020 May; 17(5):e1003113. PubMed ID: 32357197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays.
    Lawn SD; Kerkhoff AD; Vogt M; Wood R
    BMC Med; 2013 Oct; 11():231. PubMed ID: 24168211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV.
    Nathavitharana RR; Lederer P; Chaplin M; Bjerrum S; Steingart KR; Shah M
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014641. PubMed ID: 34416013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa.
    Hanifa Y; Fielding KL; Chihota VN; Adonis L; Charalambous S; Karstaedt A; McCarthy K; Nicol MP; Ndlovu NT; Sahid F; Churchyard GJ; Grant AD
    PLoS One; 2016; 11(6):e0156866. PubMed ID: 27271432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.